Literature DB >> 6418064

Susceptible Escherichia coli cells can actively excrete tetracyclines.

L M McMurry, D A Aronson, S B Levy.   

Abstract

Escherichia coli shows severalfold less susceptibility to tetracyclines when grown in enriched medium than in minimal medium. Transport studies with cells harvested from these media showed different handling of the drugs. Whereas an energy-dependent uptake of tetracycline and minocycline was observed in susceptible K-12 and wild-type E. coli strains grown in minimal medium, an active efflux of minocycline and, to a lesser extent, tetracycline was seen in cells grown in L broth and other enriched media. This efflux was replaced by an active uptake system after treatment of cells grown in L broth with EDTA. When assayed at a lower temperature (27 degrees C), even cells grown in minimal medium showed an efflux of minocycline. Everted membrane vesicles prepared from susceptible cells grown in minimal medium or L broth showed an energy-dependent accumulation of minocycline and tetracycline when supplied with certain divalent cations. These results suggest that an active efflux of tetracyclines occurs in susceptible E. coli but is not detected in cells grown in minimal medium because greater permeability of the outer membrane allows a more rapid active uptake. This efflux system is distinct from that specified by tetracycline resistance determinants. Since the active efflux of minocycline in cells grown in L broth disappeared at external antibiotic concentrations of greater than 100 microM, it may be saturable and so mediated by a membrane carrier.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6418064      PMCID: PMC185371          DOI: 10.1128/AAC.24.4.544

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  28 in total

1.  pH dependence of carbon-13 nuclear magnetic resonance shifts of tetracycline. Microscopic dissociation constants.

Authors:  G L Asleson; C W Frank
Journal:  J Am Chem Soc       Date:  1976-08-04       Impact factor: 15.419

2.  Chemical-structural properties of tetracycline derivatives. 1. Molecular structure and conformation of the free base derivatives.

Authors:  J J Stezowski
Journal:  J Am Chem Soc       Date:  1976-09-15       Impact factor: 15.419

3.  Sodium-proton antiport in isolated membrane vesicles of Escherichia coli.

Authors:  S Schuldiner; H Fishkes
Journal:  Biochemistry       Date:  1978-02-21       Impact factor: 3.162

4.  Ribosome-tetracycline interactions.

Authors:  T R Tritton
Journal:  Biochemistry       Date:  1977-09-06       Impact factor: 3.162

Review 5.  Conservation and transformation of energy by bacterial membranes.

Authors:  F M Harold
Journal:  Bacteriol Rev       Date:  1972-06

6.  Studies on the permeability change produced in coliform bacteria by ethylenediaminetetraacetate.

Authors:  L Leive
Journal:  J Biol Chem       Date:  1968-05-10       Impact factor: 5.157

7.  A complementation analysis of the restriction and modification of DNA in Escherichia coli.

Authors:  H W Boyer; D Roulland-Dussoix
Journal:  J Mol Biol       Date:  1969-05-14       Impact factor: 5.469

8.  Visualization of membrane bound cations by a fluorescent technique.

Authors:  A H Caswell; J D Hutchison
Journal:  Biochem Biophys Res Commun       Date:  1971-01-08       Impact factor: 3.575

Review 9.  The barrier function of the gram-negative envelope.

Authors:  L Leive
Journal:  Ann N Y Acad Sci       Date:  1974-05-10       Impact factor: 5.691

10.  Functional mosaicism of membrane proteins in vesicles of Escherichia coli.

Authors:  L W Adler; B P Rosen
Journal:  J Bacteriol       Date:  1977-02       Impact factor: 3.490

View more
  15 in total

Review 1.  Active efflux mechanisms for antimicrobial resistance.

Authors:  S B Levy
Journal:  Antimicrob Agents Chemother       Date:  1992-04       Impact factor: 5.191

2.  Effects of toluene permeabilization and cell deenergization on tetracycline resistance in Escherichia coli.

Authors:  L M McMurry; M Hendricks; S B Levy
Journal:  Antimicrob Agents Chemother       Date:  1986-04       Impact factor: 5.191

3.  Active efflux of chloramphenicol in susceptible Escherichia coli strains and in multiple-antibiotic-resistant (Mar) mutants.

Authors:  L M McMurry; A M George; S B Levy
Journal:  Antimicrob Agents Chemother       Date:  1994-03       Impact factor: 5.191

4.  Accumulation of trospectomycin by strains of Salmonella typhimurium, Escherichia coli and Haemophilus influenzae.

Authors:  S Wong; L Bryan
Journal:  Can J Infect Dis       Date:  1990

5.  Endogenous active efflux of norfloxacin in susceptible Escherichia coli.

Authors:  S P Cohen; D C Hooper; J S Wolfson; K S Souza; L M McMurry; S B Levy
Journal:  Antimicrob Agents Chemother       Date:  1988-08       Impact factor: 5.191

6.  Erythromycin and azithromycin transport into Haemophilus influenzae ATCC 19418 under conditions of depressed proton motive force (delta mu H).

Authors:  J O Capobianco; R C Goldman
Journal:  Antimicrob Agents Chemother       Date:  1990-09       Impact factor: 5.191

7.  The innate growth bistability and fitness landscapes of antibiotic-resistant bacteria.

Authors:  J Barrett Deris; Minsu Kim; Zhongge Zhang; Hiroyuki Okano; Rutger Hermsen; Alexander Groisman; Terence Hwa
Journal:  Science       Date:  2013-11-29       Impact factor: 47.728

8.  Factors influencing the accumulation of ciprofloxacin in Pseudomonas aeruginosa.

Authors:  R A Celesk; N J Robillard
Journal:  Antimicrob Agents Chemother       Date:  1989-11       Impact factor: 5.191

9.  Tetracyclines of various hydrophobicities as a probe for permeability of Escherichia coli outer membranes.

Authors:  L Leive; S Telesetsky; W G Coleman; D Carr
Journal:  Antimicrob Agents Chemother       Date:  1984-05       Impact factor: 5.191

10.  Comparison of Minocycline Susceptibility Testing Methods for Carbapenem-Resistant Acinetobacter baumannii.

Authors:  Peng Wang; Sarah L Bowler; Serena F Kantz; Roberta T Mettus; Yan Guo; Christi L McElheny; Yohei Doi
Journal:  J Clin Microbiol       Date:  2016-09-14       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.